Phosphoinositide and redox dysregulation by the anticancer methylthioadenosine phosphorylase transition state

Timothy Salita1, Yepy H Rustam2, Vinzenz Hofferek3

  • 1School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand; Department of Biochemistry and Pharmacology, University of Melbourne, Parkville, Australia.

Insights

Methylthio-DADMe-immucillin-A (MTDIA) inhibits 5'-methylthioadenosine phosphorylase (MTAP), impacting cancer cell lipidomes. This study reveals MTDIA alters lipid signaling and immune responses, suggesting a novel therapeutic mechanism.

Area of Science:

  • Biochemistry
  • Cancer Biology
  • Metabolomics

Background:

  • 5'-methylthioadenosine phosphorylase (MTAP) is implicated in cancer progression.
  • MTAP inhibition is a potential anti-cancer therapeutic strategy.
  • S-adenosylmethionine (SAM), salvaged by MTAP, is crucial for lipid metabolism.

Purpose of the Study:

  • To investigate the effects of the MTAP inhibitor Methylthio-DADMe-immucillin-A (MTDIA) on cellular lipidomes.
  • To identify lipidomic changes associated with MTAP inhibition.
  • To explore the downstream consequences of MTDIA-induced lipid alterations.

Main Methods:

  • Lipid profiling of MTDIA-treated Saccharomyces cerevisiae using ultra-high resolution accurate mass spectrometry (UHRAMS).
  • Analysis of lipidomic changes upon MTAP inhibition and MTAP gene knockout.
  • Validation of the phosphoinositide kinase/phosphatase signaling network alterations.

Main Results:

  • MTDIA treatment and MTAP knockout induced global lipidomic changes in yeast.
  • Specific alterations in lipids involved in cell signaling, particularly the phosphoinositide pathway, were observed.
  • Dysregulated lipid metabolism correlated with decreased reactive oxygen species (ROS) and modulated immune response factors in mammalian cells.

Conclusions:

  • MTDIA significantly alters cellular lipid homeostasis.
  • MTAP inhibition affects lipid signaling networks, impacting cellular functions.
  • Lipidomic alterations may contribute to the anti-cancer efficacy of MTDIA.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K